453 related articles for article (PubMed ID: 22992742)
1. Rho isoform-specific interaction with IQGAP1 promotes breast cancer cell proliferation and migration.
Casteel DE; Turner S; Schwappacher R; Rangaswami H; Su-Yuo J; Zhuang S; Boss GR; Pilz RB
J Biol Chem; 2012 Nov; 287(45):38367-78. PubMed ID: 22992742
[TBL] [Abstract][Full Text] [Related]
2. A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells.
Wang L; Yang L; Luo Y; Zheng Y
J Biol Chem; 2003 Nov; 278(45):44617-25. PubMed ID: 12939257
[TBL] [Abstract][Full Text] [Related]
3. The Role of RhoA, RhoB and RhoC GTPases in Cell Morphology, Proliferation and Migration in Human Cytomegalovirus (HCMV) Infected Glioblastoma Cells.
Tseliou M; Al-Qahtani A; Alarifi S; Alkahtani SH; Stournaras C; Sourvinos G
Cell Physiol Biochem; 2016; 38(1):94-109. PubMed ID: 26741994
[TBL] [Abstract][Full Text] [Related]
4. RhoC regulates the proliferation of gastric cancer cells through interaction with IQGAP1.
Wu Y; Tao Y; Chen Y; Xu W
PLoS One; 2012; 7(11):e48917. PubMed ID: 23145020
[TBL] [Abstract][Full Text] [Related]
5. Divergence of Rho residue 43 impacts GEF activity.
Sloan CM; Quinn CV; Peters JP; Farley J; Goetzinger C; Wernli M; DeMali KA; Ellerbroek SM
Small GTPases; 2012; 3(1):15-22. PubMed ID: 22673745
[TBL] [Abstract][Full Text] [Related]
6. Myosin-interacting guanine exchange factor (MyoGEF) regulates the invasion activity of MDA-MB-231 breast cancer cells through activation of RhoA and RhoC.
Wu D; Asiedu M; Wei Q
Oncogene; 2009 Jun; 28(22):2219-30. PubMed ID: 19421144
[TBL] [Abstract][Full Text] [Related]
7. Effects of lovastatin on Rho isoform expression, activity, and association with guanine nucleotide dissociation inhibitors.
Turner SJ; Zhuang S; Zhang T; Boss GR; Pilz RB
Biochem Pharmacol; 2008 Jan; 75(2):405-13. PubMed ID: 17920041
[TBL] [Abstract][Full Text] [Related]
8. RhoC protein stimulates migration of gastric cancer cells through interaction with scaffold protein IQGAP1.
Wu Y; Chen YC; Sang JR; Xu WR
Mol Med Rep; 2011; 4(4):697-703. PubMed ID: 21537845
[TBL] [Abstract][Full Text] [Related]
9. XPLN, a guanine nucleotide exchange factor for RhoA and RhoB, but not RhoC.
Arthur WT; Ellerbroek SM; Der CJ; Burridge K; Wennerberg K
J Biol Chem; 2002 Nov; 277(45):42964-72. PubMed ID: 12221096
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.
Bourguignon LY; Wong G; Earle C; Krueger K; Spevak CC
J Biol Chem; 2010 Nov; 285(47):36721-35. PubMed ID: 20843787
[TBL] [Abstract][Full Text] [Related]
11. Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters.
Fritz G; Brachetti C; Bahlmann F; Schmidt M; Kaina B
Br J Cancer; 2002 Sep; 87(6):635-44. PubMed ID: 12237774
[TBL] [Abstract][Full Text] [Related]
12. RhoA, RhoB and RhoC have different roles in cancer cell migration.
Ridley AJ
J Microsc; 2013 Sep; 251(3):242-9. PubMed ID: 23488932
[TBL] [Abstract][Full Text] [Related]
13. Mouse macrophages completely lacking Rho subfamily GTPases (RhoA, RhoB, and RhoC) have severe lamellipodial retraction defects, but robust chemotactic navigation and altered motility.
Königs V; Jennings R; Vogl T; Horsthemke M; Bachg AC; Xu Y; Grobe K; Brakebusch C; Schwab A; Bähler M; Knaus UG; Hanley PJ
J Biol Chem; 2014 Oct; 289(44):30772-30784. PubMed ID: 25213860
[TBL] [Abstract][Full Text] [Related]
14. DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms.
Healy KD; Hodgson L; Kim TY; Shutes A; Maddileti S; Juliano RL; Hahn KM; Harden TK; Bang YJ; Der CJ
Mol Carcinog; 2008 May; 47(5):326-37. PubMed ID: 17932950
[TBL] [Abstract][Full Text] [Related]
15. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.
Pillé JY; Denoyelle C; Varet J; Bertrand JR; Soria J; Opolon P; Lu H; Pritchard LL; Vannier JP; Malvy C; Soria C; Li H
Mol Ther; 2005 Feb; 11(2):267-74. PubMed ID: 15668138
[TBL] [Abstract][Full Text] [Related]
16. A current overview of RhoA, RhoB, and RhoC functions in vascular biology and pathology.
Eckenstaler R; Hauke M; Benndorf RA
Biochem Pharmacol; 2022 Dec; 206():115321. PubMed ID: 36306821
[TBL] [Abstract][Full Text] [Related]
17. RhoGDIα-dependent balance between RhoA and RhoC is a key regulator of cancer cell tumorigenesis.
Giang Ho TT; Stultiens A; Dubail J; Lapière CM; Nusgens BV; Colige AC; Deroanne CF
Mol Biol Cell; 2011 Sep; 22(17):3263-75. PubMed ID: 21757538
[TBL] [Abstract][Full Text] [Related]
18. Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility.
Wheeler AP; Ridley AJ
Exp Cell Res; 2004 Nov; 301(1):43-9. PubMed ID: 15501444
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor stimulates human trophoblast cell migration through Rho A and Rho C activation.
Han J; Li L; Hu J; Yu L; Zheng Y; Guo J; Zheng X; Yi P; Zhou Y
Endocrinology; 2010 Apr; 151(4):1732-42. PubMed ID: 20150581
[TBL] [Abstract][Full Text] [Related]
20. Regulation of Leukaemia Associated Rho GEF (LARG/ARHGEF12).
Ghanem NZ; Matter ML; Ramos JW
Small GTPases; 2022 Jan; 13(1):196-204. PubMed ID: 34304710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
